TISSUE POLYPEPTIDE ANTIGEN IS A USEFUL TUMOR-MARKER IN BREAST-CANCER

被引:0
|
作者
OHANLON, DM
KERIN, M
KENT, P
MAHER, D
GRIMES, H
GIVEN, HF
机构
[1] NATL UNIV IRELAND UNIV COLL GALWAY,DEPT BIOCHEM,GALWAY,IRELAND
[2] NATL UNIV IRELAND UNIV COLL GALWAY,DEPT SURG,GALWAY,IRELAND
[3] NATL UNIV IRELAND UNIV COLL GALWAY,NATL BREAST CANC RES INST,GALWAY,IRELAND
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:763 / 763
页数:1
相关论文
共 50 条
  • [41] DIFFERENTIAL IMMUNOCYTOCHEMICAL LOCALIZATION OF TISSUE POLYPEPTIDE ANTIGEN (TPA) AND CARCINOEMBRYONIC ANTIGEN (CEA) IN BREAST-CANCER
    BJORKLUND, V
    BJORKLUND, B
    CANCER DETECTION AND PREVENTION, 1983, 6 (1-2): : 193 - 198
  • [42] CREATINE KINASE-BB ISOENZYME AS A TUMOR-MARKER IN BREAST-CANCER, LUNG-CANCER, AND LYMPHOMA
    RUBERY, ED
    DORAN, JF
    THOMPSON, RJ
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1983, 417 (DEC) : 410 - 426
  • [43] CIRCULATING IMMUNE-COMPLEXES (CIC) AS TUMOR-MARKER IN THE FOLLOW-UP OF BREAST-CANCER
    NERI, B
    CIATTO, S
    DISTANTE, V
    COMPARINI, T
    CATALIOTTI, L
    BARTALUCCI, S
    CANCER DETECTION AND PREVENTION, 1985, 8 (1-2): : 53 - 56
  • [44] TUMOR-MARKER CA-15-3 AND ESTROGEN-PROGESTIN RECEPTORS IN BREAST-CANCER
    SUNDARAM, GS
    MANIMEKALAI, S
    UNNI, S
    THILAKAVATHI, G
    GOLDSTEIN, PJ
    BHAGAVAN, BS
    CLINICAL CHEMISTRY, 1988, 34 (06) : 1297 - 1297
  • [45] VALUE OF TUMOR-MARKER DETERMINATION IN FOLLOW-UP OF BREAST-CANCER - PROSPECTIVE-STUDY
    SCHMIDTRHODE, P
    VALET, A
    ZWIOREK, L
    SCHULZ, KD
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1991, 250 (1-4) : 281 - 282
  • [46] IDENTIFICATION OF A PUTATIVE TUMOR-MARKER IN BREAST AND COLON CANCER
    SU, BY
    KAPPLER, F
    SZWERGOLD, BS
    BROWN, TR
    CANCER RESEARCH, 1993, 53 (08) : 1751 - 1754
  • [47] TUMOR-MARKER COURSES TO ASSESS THE EFFICACY OF CHEMOTHERAPY OR HORMONE-THERAPY IN METASTASIZING BREAST-CANCER
    MOBUS, V
    PAULA, J
    BECK, T
    CROMBACH, G
    KREIENBERG, R
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1993, 53 (01) : 24 - 29
  • [48] TUMOR-MARKER CA15-3 - POSSIBLE USES IN THE ROUTINE MANAGEMENT OF BREAST-CANCER
    TOMLINSON, IPM
    WHYMAN, A
    BARRETT, JA
    KREMER, JK
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (06) : 899 - 902
  • [49] EVALUATION OF 140.72 ANTIGEN AS A TUMOR-MARKER
    RYAN, ED
    DENT, PB
    MERANDA, C
    LIAO, SK
    TUMOR BIOLOGY, 1987, 8 (06) : 323 - 323
  • [50] CARCINOEMBRYONIC ANTIGEN AS A CLINICAL TUMOR-MARKER
    DEPPE, G
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1981, 1 (05): : 272 - 272